Navigation Links
US Patent Office Grants McCord Research Endothelial Cell Treatment Patent
Date:7/21/2014

CORALVILLE, Iowa, July 21, 2014 /PRNewswire/ -- McCord Research, Inc. was recently granted a second US patent (U.S. Patent No. 8,796,315). This patent describes a method for accelerating wound closure to improve wound healing.  According to the inventor, Dr. McCord, this method includes administering or transplanting to individuals who require wound healing, a composition of an effective amount of hydroxytyrosol and oleuropein and cells derived from umbilical cord blood, such that the administration of the combination reduces the time required for wound healing by at least approximately 30% in comparison to treatment with just cells derived from umbilical cord blood alone.

Endothelial cells form the inner lining of a blood vessel and provides an anticoagulant barrier between the vessel wall and blood. Endothelial cells have a vital role in wound repair especially for patients with vascular disease and diabetes.  The restoration of these cells allows for vital nutrients to be delivered to the skin and wound through the small network of capillaries that form at the dermal epidermal junction. The endothelial cells additionally regulate hemostasis, vasomotor tone, angiogenesis and vasculogenesis and immune and inflammatory responses. In addition, the endothelial cell plays a pivotal role in wound care. "Endothelial cell injury is the genesis of many pathologic states including atherosclerosis, loss of semi-permeable membrane function, and thrombosis. Restoring the viability of endothelial cells has far reaching health implications," stated Dr. McCord.

McCord Research is seeking worldwide patent protection for its wound care technology and looks forward to healing wounds on a global basis. The technology is currently being licensed under the Olivamine 10® brand name in the United States and Asia for the treatment of wounds in humans and animals.

McCord Research, Inc. corporate offices are located at 2769 Heartland Drive in Coralville, IA.
For further information call 319-358-5536 or www.mccordresearch.com.  

www.olivamine.com
www.mccordresearch.com
www.facebook.com/mccordresearch

For Further Information:
Darlene McCord, Ph.D., CEO, CSO
McCord Research/Pinnaclife, Inc.
inquire@mccordresearch.com
319-351-3201

Logo - http://photos.prnewswire.com/prnh/20120510/CG05130LOGO


'/>"/>
SOURCE McCord Research, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. ITC Rules Redesigned APEX Humidifier Still Infringes ResMed Patents
2. BMC to Actively Defend against Curative in Patent Fight
3. Columbia Laboratories Expands its Intellectual Property Portfolio Following Receipt of U.S. Patent
4. The Medicines Patent Pool Signs a Record Seven New Sub-Licences to Speed the Availability of Generic HIV Medicines to Developing Countries
5. Diomics Announces Issuance Of U.S. Patents For Novel Biologic Sample DNA Collection Materials For Use In Forensics And Diagnostics
6. MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics
7. Fuisz Pharma LLC Announces Patent Filing for Novel System and Method to Obtain Blood for Diagnostic Analysis Using a Lancet or Needle Puncture
8. CorMedix Awarded European Patent for Neutrolin
9. Puritan Medical Products erhält zwei neue Patente für beflockte Tupfer in Japan
10. Puritan Medical Products Recebe Duas Novas Patentes Swab com Algodão no Japão
11. Puritan Medical Products Awarded Two New Flocked Swab Patents in Japan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... , Feb 23, 2017 Research and ... Devices Market Analysis & Trends - Industry Forecast to 2025" ... ... grow at a CAGR of around 9.2% over the next decade ... report analyzes the market estimates and forecasts for all the given ...
(Date:2/23/2017)... , February 23, 2017 Tillotts ... the Berlin office was opened ... Kritikos . The portfolio includes Entocort ® for ... the treatment of ulcerative colitis, and VistaPrep ® ... the Swiss specialty pharmaceutical company focused on the treatment ...
(Date:2/23/2017)... NEW YORK , Feb. 23, 2017 ... presentations and one poster presentation at PittCon ... Chicago IL.  Pittcon is the world,s largest ... science and serves a wide array of ... sciences, pharmaceutical discovery and QA, food safety, ...
Breaking Medicine Technology:
(Date:2/22/2017)... ... February 22, 2017 , ... South Bend’s Lunkerville, the ... once again feature Heroes On The Water (HOW), a non-profit organization dedicated to helping ... episode has series host ‘Mike D’ traveling to Lake Denmark, New Jersey, to fish ...
(Date:2/22/2017)... ... February 22, 2017 , ... A cylindrical “pipeline” used for ... to reach ones, according to the results of a clinical trial announced Wednesday. ... by Ricardo A. Hanel, MD, PhD, neurovascular surgeon with Baptist Health and Lyerly ...
(Date:2/22/2017)... ... ... Using the power of the internet, IdrisArkette.com has managed to produce more ... just 24 months, thousands of individuals interested in a medical procedure managed to be ... is not getting quieter. In fact it’s becoming noisier by the day. If you ...
(Date:2/22/2017)... ... February 22, 2017 , ... Becker’s Spine Review, ... is featuring Michigan neurosurgeon Jay Jagannathan, M.D., as a “Spine Surgeon to Know.” ... of neurosurgeons in Michigan performing minimally invasive back surgery that often results in ...
(Date:2/22/2017)... , ... February 22, 2017 , ... ... and 72 percent of those report that family members or friends have also ... they suffer from hearing loss wear hearing aids. One reason, suggested by 89 ...
Breaking Medicine News(10 mins):